Gene expression of lipoprotein lipase in experimental nephrosis

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 4, 1997, Pages 387-394

  Liang, Kaihui ^a   Vaziri, Nosratola D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031258643     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90038-X     Document Type: Article

References (35)

1. Auwerk J, Leroy P, Schoonjans K. Lipoprotein lipase: recent contributions from molecular biology. Crit Rev Clin Lab Sci 1992;29:243-68.
2. Felts JM, Itakura H, Crane RT. The mechanism of assimilation of constituents of chylomicrons, very low density lipoproteins and remnants: a new theory. Biochim Biophys Res Commun 1975;66:1467-75.
3. Goldberg IJ, Kandel JJ, BlumCB, Ginsberg Association of plasma lipoproteins with post-heparin activities. J Clin Invest 1986;78:1523-8.
4. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chyomicrons to low-density lipoprotein receptor-related protein. Proc Natl Acad Sci USA 1991;88:8342-6.
5. Kaysen GA. Hyperlipidemia of the nephrotic syndrome. Kidney Int 1991;39:S8-S15.
6. Marsh JB. Lipoprotein metabolism in experimental nephrosis. J Lipid Res 1984;25:1619-23.
7. Staprans I, Felts JM, Couser WG. Glycosaminoglycans and chylomicron metabolism in control and nephrotic rats. Metabolism 1987;36:496-501.
8. Joven J, Villabona C, Vilella E, Masana L, Alberti R, Valles M. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med 1990;323:579-84.
9. Gherardi E, Rota E, Calandra S, Genova R, Tamborino A. Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome. Eur J Clin Invest 1977;7:563-70.
10. Stenvinkel P, Berglund L, Heimburger O, Petterson E, Alvestrand A. Lipoprotein (a) in nephrotic syndrome. Kidney Int 1993;44:1116-23.
11. Levy E, Ziv E, Bar-On H, Shafrir E. Experimental nephrotic syndrome: removal and tissue distribution of chylomicrons and very-low density lipoproteins of normal and nephrotic origin. Biochim Biophys Acta 1990;1043:259-66.
12. Kronenberg F, Uterman G, Dieplinger H. Lipoprotein (a) in renal diseases. Am J Kidney Dis 1996;27:1-25.
13. Vaziri ND, Liang KH. Hepatic HMG-CoA reductase gene expression in the course of puromycin-induced nephroeis. Kidney Int 1995;48: 1979-85.
14. Liang KH, Oveisi F, Vaziri ND. Gene expression of hepatic cholesterol 7α-hydroxylase in the course of puromycin-induced nephrosis. Kidney Int 1996;49:855-60.
15. Vaziri ND, Liang KH. Down regulation of hepatic LDL receptor in experimental nephrosis. Kidney Int 1996;50:887-93.
16. Liang K, Vaziri ND. Down regulation of hepatic lipase expression in experimental nephrotic syndrome. Kidney Int 1997;51:1933-7.
17. Liang K, Vaziri ND. Acquired VLDL receptor deficiency in experimental nephrosis. Kidney Int 1997;51:1761-5.
18. Kaysen GA, Mehendru L, Pan XM, Staprans I. Both peripheral chylomicron catabolism and hepatic uptake of remnants are defective in nephrosis. Am J Physiol 1992;263:F335-41.
19. Kashyap ML, Srivastava LS, Hynd BA, Brady D, Perisutt G, Glueck CJ, et al. Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome. Atherosclerosis 1980;35:29-40.
20. Antikainen M, Holmberg C, Olivecrona T, Bengtsson-Olivercrona G, Labeur C, Rosseneu M, et al. Changes in biological activity and immunoreactive mass of lipoprotein lipase in congenital nephrosis: relationship to hypertriglyceridaemia. Eur J Clin Invest 1993;23:368-74.
21. Kirschgessner TG, Svenson KL, Lusis AJ, Schotz MC. The sequence of cDNA encoding lipoprotein lipase. J Biol Chem 1987;262:8463-6.
22. Iverius PH, Ostlund-Lindqvist AM. Preparation, characterization and measurement of lipoprotein lipase. Methods Enzymol 1986;129:691-704.
23. Simsolo RB, Ong JM, Kern PA. The regulation of adipose tissue and muscle lipoprotein lipase in runners by detraining. J Clin Invest 1993;92:2124-30.
24. Goers JWF, Pedersen ME, Kern PA, Ong J, Schotz MC. An enzyme-linked immunoassay for lipoprotein lipase. Anal Biochem 1987;166:27-35.
25. Davies RW, Staprans I, Hutchinson FN, Kaysen GA. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat. J Clin Invest 1990;86:600-5.
26. Doolittle MH, Ben-Zeev O, Elovson J, Martin D, Kirchgessner TG. The response of lipoprotein lipase to feeding and fasting: evidence for posttranslational regulation. J Biol Chem 1990;265:4570-7.
27. Ong JM, Saffari B, Simsolo RB, Kern PA. Epinephrine inhibits lipoprotein lipase gene expression in rat adipocytes through multiple steps in posttranscriptional processing. Mol Endocrinol 1992;6:61-9.
28. Saffari B, Ong JM, Kern PA. Regulation of adipose tissue lipoprotein lipase gene expression by thyroid hormone in rats. J Lipid Res 1992;33:241-9.
29. Carroll R, Ben-Zeev O, Doolittle MH, Severson DL. Activation of lipoprotein lipase in cardiac myocytes by glycosylation requires trimming of glucose residues in the endoplasmic reticulum. Biochem J 1992;285:693-6.
30. Simsolo RB, Ong JM, Kern PA. Characterization of lipoprotein lipase activity, secretion, and degradation at different sites of post-translational processing in primary cultures of rat adipocytes. J Lipid Res 1992;33:1777-84.
31. Ben-Zeev O, Doolittle MH, Davis RC, Elovson J, Schotz MC. Maturation of lipoprotein lipase: expression of full catalytic activity requires glucose trimming but not translocation to the cis-Golgi compartment. J Biol Chem 1992; 267:6219-27.
32. Vaziri ND, Liang K. Down regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int 1996;50:1928-35.
33. Vaziri ND, Liang K. Down regulation of VLDL receptor expression in chronic experimental renal failure. Kidney Int 1977;51:913-9.
34. Vaziri ND, Wang XQ, Liang K. Role of secondary hyperparathyroidism in the pathogenesis of depressed lipoprotein lipase expression in chronic renal failure. Am J Physiol (in press).
35. Khamiseh G, Vaziri ND, Oveisi F, Ahmadnia M, Ahmadnia L. Vitamin D absorption, plasma concentration and urinary excretion of 25-hydroxyvitamin D in nephrotic syndrome. Proc Soc Exp Biol Med 1991;196:210-3.